×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:
Year Range:

-
Journal
Authors

4453 Total Publications

BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer’s Disease.
Gaser, C., Franke, K., Klöppel, S., Koutsouleris, N., & Sauer, H.
2013; Journal PloS One; vol. 8; no. 6; pp. e67346; doi:10.1371/journal.pone.0067346
CSF alpha-synuclein improves diagnostic and prognostic performance of CSF tau and Abeta in Alzheimer’s disease.
Toledo, J. B., Korff, A., Shaw, L. M., Trojanowski, J. Q., & Zhang, J.
2013; Journal Acta Neuropathologica; vol. 126; no. 5; pp. 683-697; doi:10.1007/s00401-013-1148-z
Sample size estimates for well-powered cross-sectional cortical thickness studies.
Pardoe, H. R., Abbott, D. F., Jackson, G. D., & Initiative, A. D. N.
2013; Journal Human Brain Mapping; vol. 34; no. 11; pp. 3000-3009; doi:10.1002/hbm.22120
α-Synuclein in cerebrospinal fluid of Alzheimer’s disease and mild cognitive impairment.
Ane Korff, PhD, Changqin Liu, MD, PhD, Carmen Ginghina, MD, Min Shi, PhD, and Jing Zhang, MD, PhD, for the Alzheimer’s Disease Neuroimaging Initiative
2013; Journal Journal of Alzheimer's Disease; vol. 36; no. 4; pp. 679-688;
Identifying multi-analyte CSF biomarkers for Alzheimer’s disease in a multi-cohort study.
Leung YY, Toledo J, Nefedov A, et al.
2013; Journal Alzheimer's and Dementia; vol. 9; no. 4; pp. 128-9;
Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease.
Llano, D. a, Devanarayan, V., & Simon, A. J.
2013; Journal Alzheimer's Disease and Associated Disorders; vol. 27; no. 3; pp. 233-43; doi:10.1097/WAD.0b013e31826d597a
Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.
Dickerson, B. C., & Wolk, D. A.
2013; Journal Frontiers in Aging Neuroscience; vol. 5; pp. 55; doi:10.3389/fnagi.2013.00055
Teichmüller shape descriptor and its application to alzheimer’s disease study.
Zeng, W., Shi, R., Wang, Y., Yau, S. T., & Gu, X.
2013; Journal International Journal of Computer Vision; vol. 105; pp. 155-170; doi:10.1007/s11263-012-0586-8
Arterial spin labeled MRI in prodromal Alzheimer’s disease: A multi-site study.
Wang, Z., Das, S. R., Xie, S. X., Arnold, S. E., Detre, J. A., & Wolk, D. A.
2013; Journal Neuroimage: Clinical; vol. 2; pp. 630-6; doi:10.1016/j.nicl.2013.04.014
Prevalence of Alzheimer’s pathologic endophenotypes in asymptomatic and mildly impaired first-degree relatives.
Lampert, E. J., Roy Choudhury, K., Hostage, C. a, Petrella, J. R., & Doraiswamy, P. M.
2013; Journal PloS One; vol. 8; no. 4; pp. e60747; doi:10.1371/journal.pone.0060747